Membrane translocation of mdm2 increases the immunogenicity of tubular epithelium via pd-l1 ubiquitination

被引：0
|
作者：
Su, H. [1 ]
Ye, C. [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Sch, Union Hosp, Nephrol, Wuhan, Hubei, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P1800
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [1] AKI-INDUCED MEMBRANE TRANSLOCATION OF MDM2 INCREASES THE IMMUNOGENICITY OF TUBULAR EPITHELIUM VIA PD-L1 UBIQUITINATION
    Su, Hua
    Zeng, Jieyu
    Ye, Chen
    HUMAN IMMUNOLOGY, 2019, 80 : 15 - 15
  • [2] Mechanism of Immunogenicity Change of Renal Tubular Epithelial Cells Induced by MDM2 Membrane Translocation in Ischemic AKI
    Zeng, Jieyu
    Su, Hua
    Zhang, Chun
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 628 - 628
  • [3] PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination
    Yu, Xinfang
    Li, Wei
    Liu, Haidan
    Wang, Xu
    Coarfa, Cristian
    Cheng, Chao
    Yu, Xinlian
    Zeng, Zhaoyang
    Cao, Ya
    Young, Ken H.
    Li, Yong
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (03):
  • [4] Coupled deglycosylation-ubiquitination cascade in regulating PD-1 degradation by MDM2
    Wu, Zhen
    Cao, Zhijie
    Yao, Han
    Yan, Xiaojun
    Xu, Wenbin
    Zhang, Mi
    Jiao, Zishan
    Zhang, Zijing
    Chen, Jianyuan
    Liu, Yajing
    Zhang, Meng
    Wang, Donglai
    CELL REPORTS, 2023, 42 (07):
  • [5] MDM2 accelerated renal senescence via ubiquitination and degradation of HDAC1
    Xiang, Hui-ling
    Yuan, Qian
    Zeng, Jie-yu
    Xu, Zi-yu
    Zhang, Hui-zi
    Huang, Jing
    Song, An-ni
    Xiong, Jing
    Zhang, Chun
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (11) : 2328 - 2338
  • [6] MDM2 Inhibition and the Efficacy of Radiotherapy and PD-L1 Antibody Combination Therapy by Reprogramming the Glioblastoma Tumor Microenvironment
    Yuan, C.
    Li, W.
    Wang, Y.
    Hu, M.
    Ding, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E293 - E293
  • [7] PD-1/PD-L1 blockade enhances MDM2 inhibitor activity in p53 wild-type cancers
    Wang, Hui Qin
    Liang, Jinsheng
    Mulford, Iain
    Sharp, Fiona
    Gaulis, Swann
    Chen, Yan
    Trabucco, Gina
    Quinn, David
    Growney, Joseph D.
    Meyer, Matthew J.
    Williams, Juliet
    Hammerman, Peter
    Hofmann, Francesco
    Dranoff, Glenn
    Engelman, Jeffrey
    Mataraza, Jennifer
    Halilovic, Ensar
    CANCER RESEARCH, 2018, 78 (13)
  • [8] Association between MDM2/MDM4 amplification and PD-1/PD-L1 inhibitors-related hyperprogressive disease: A pan-cancer analysis
    Ju, Weiqiang
    Chen, Shiqing
    Wang, Guoqiang
    Cai, Shangli
    Xiong, Jianping
    Xiang, Xiaojun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Ubiquitination of MDM2 modulated by Epstein-Barr virus encoded latent membrane protein 1
    Li, Lili
    Li, Zijian
    Zhou, Shanghui
    Xiao, Lanbo
    Guo, Lili
    Tao, Yongguang
    Tang, Min
    Shi, Ying
    Li, Wei
    Yi, Wei
    Cao, Ya
    VIRUS RESEARCH, 2007, 130 (1-2) : 275 - 280
  • [10] RETRACTED: SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53 (Retracted Article)
    Buschmann, T
    Fuchs, SY
    Lee, CG
    Pan, ZQ
    Ronai, Z
    CELL, 2000, 101 (07) : 753 - 762
12345